capivasertib 160 MG Oral Tablet
Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
capivasertib 160 MG Oral Tablet
160 MG · Oral Tablet · oral
A form of capivasertib →
capivasertib 160 MG Oral Tablet — Other protein kinase inhibitors. Strength, form, class, interactions & more.
Active ingredient
Classification
Other protein kinase inhibitors
Drug interactions
Capivasertib has several drug interactions primarily involving CYP3A inhibitors and inducers.
- majorstrong CYP3A inhibitors — increased risk of TRUQAP adverse reactions
- moderatemoderate CYP3A inhibitors — increased risk of TRUQAP adverse reactions
- majorstrong CYP3A inducers — reduced effectiveness of TRUQAP
- majormoderate CYP3A inducers — reduced effectiveness of TRUQAP
Real-world adverse events (FAERS)
Diarrhoea382Death357Rash343Hyperglycaemia248Nausea136Malignant Neoplasm Progression109Vomiting108Fatigue107
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication